59 h. ago Bitget Stock Futures Break Through $10 Billion as Global Traders Rush Into Tokenized Equities

VICTORIA, Seychelles, Dec. 03, 2025 (GLOBE NEWSWIRE) — Bitget, the world’s largest Universal Exchange (UEX), today announced that its US stock futures have surpassed $10 billion in cumulative trading volume. The milestone comes just two weeks after crossing the $5 billion mark, highlighting extraordinary market momentum and accelerating user demand for tokenized stock futures. The […]

Economics

3 d. ago US Firms Are Snapping Up the Rare Earths Europe Needs to Rearm

As Europe embarks on a historic rearming effort, its defense companies are scrambling for a vital component in high-tech weapons: rare earth minerals, which more nimble US rivals are scooping up.

Economics

5 d. ago Global Stock Leaderboards Are Ruled by Europe in Rare Dominance

In the ranks of the world’s 20 best-performing stock markets this year, every second index is European.

Economics

2 w. ago Bitget Shatters New Milestone with $5B in Stock Futures Cumulative Trading Volume

VICTORIA, Seychelles, Nov. 19, 2025 (GLOBE NEWSWIRE) — Bitget, the world’s largest Universal Exchange (UEX), today announced a new milestone for its fast-growing stock futures product line, surpassing $5 billion in cumulative trading volume. The achievement comes just one week after crossing the $3 billion mark, highlighting accelerating global demand for tokenized stock futures. The […]

Economics

2 w. ago European Magnet Maker Warns of Rare Earth Crisis Without Action

Europe needs to take much more decisive action to slash reliance on Chinese rare earths to avert worse supply disruptions, according to a German magnet maker that’s just started a plant in the US.

Economics

2 w. ago High Dose Regimen of Nusinersen Receives Positive CHMP Opinion for the Treatment of Spinal Muscular Atrophy

Positive CHMP opinion is based on data from the DEVOTE study which evaluated the high dose regimen of nusinersen in treatment-naive participants and those transitioning from the currently approved 12mg dose regimen1 Final European Commission decision expected in January 2026 SMA is a rare, genetic, neuromuscular disease that affects individuals of all ages2 CAMBRIDGE, Mass., […]

Economics